Craighead Daniel H, McCartney Nathaniel B, Tumlinson James H, Alexander Lacy M
The Pennsylvania State University, University Park, PA 16802, United States.
The Pennsylvania State University, University Park, PA 16802, United States.
Microvasc Res. 2017 Mar;110:43-47. doi: 10.1016/j.mvr.2016.11.008. Epub 2016 Nov 27.
Menthol is a vasoactive compound that is widely used in topical analgesic agents. Menthol induces cutaneous vasodilation, however the underlying mechanisms are unknown. Determining the rates of appearance and clearance of menthol in the skin is important for optimizing topical treatment formulation and dosing. The purpose of this study was to determine the mechanisms contributing to menthol-mediated cutaneous vasodilation and to establish a time course for menthol appearance/clearance in the skin. Ten young (23±1years, 5 males 5 females) subjects participated in two protocols. In study 1, four intradermal microdialysis fibers were perfused with increasing doses of menthol (0.1-500mM) and inhibitors for nitric oxide (NO), endothelium derived hyperpolarizing factors (EDHFs), and sensory nerves. Skin blood flow was measured with laser Doppler flowmetry and normalized to %CVC. In study 2, two intradermal microdialysis fibers were perfused with lactated Ringer's solution. 0.017mL·cm of a 4% menthol gel was placed over each fiber. 5μL samples of dialysate from the microdialysis fibers were collected every 30min and analyzed for the presence of menthol with high performance gas chromatography/mass spectrometry. Skin blood flow (laser speckle contrast imaging) and subjective ratings of menthol sensation were simultaneously obtained with dialysate samples. In study 1, menthol induced cutaneous vasodilation at all doses ≥100mM (all p<0.05). However, inhibition of either NO, EDHFs, or sensory nerves fully inhibited menthol-mediated vasodilation (all p>0.05). In study 2, significant menthol was detected in dialysate 30min post menthol application (0.89ng, p=0.0002). Relative to baseline, cutaneous vasodilation was elevated from minutes 15-45 and ratings of menthol sensation were elevated from minute 5-60 post menthol application (all p<0.05). Menthol induces cutaneous vasodilation in the skin through multiple vasodilator pathways, including NO, EDHF, and sensory nerves. Topical menthol is detectable in the skin within 30min and is cleared by 60min. Skin blood flow and perceptual measures follow a similar time course as menthol appearance/clearance.
薄荷醇是一种血管活性化合物,广泛用于局部镇痛剂。薄荷醇可诱导皮肤血管舒张,但其潜在机制尚不清楚。确定薄荷醇在皮肤中的出现率和清除率对于优化局部治疗配方和剂量很重要。本研究的目的是确定导致薄荷醇介导的皮肤血管舒张的机制,并建立薄荷醇在皮肤中的出现/清除时间进程。十名年轻(23±1岁,5名男性5名女性)受试者参与了两项方案。在研究1中,四根皮内微透析纤维用递增剂量的薄荷醇(0.1 - 500mM)以及一氧化氮(NO)、内皮衍生超极化因子(EDHFs)和感觉神经的抑制剂进行灌注。用激光多普勒血流仪测量皮肤血流量并归一化为%CVC。在研究2中,两根皮内微透析纤维用乳酸林格氏液进行灌注。在每根纤维上放置0.017mL·cm的4%薄荷醇凝胶。每隔30分钟从微透析纤维收集5μL透析液样品,并用高效气相色谱/质谱法分析薄荷醇的存在情况。在收集透析液样品的同时,用激光散斑对比成像法测量皮肤血流量,并对薄荷醇感觉进行主观评分。在研究1中,所有剂量≥100mM的薄荷醇均诱导皮肤血管舒张(所有p<0.05)。然而,抑制NO、EDHFs或感觉神经均可完全抑制薄荷醇介导的血管舒张(所有p>0.05)。在研究2中,在应用薄荷醇后30分钟,透析液中检测到显著量的薄荷醇(0.89ng,p = 0.0002)。相对于基线,皮肤血管舒张在应用薄荷醇后15 - 45分钟升高,薄荷醇感觉评分在应用薄荷醇后5 - 60分钟升高(所有p<0.05)。薄荷醇通过多种血管舒张途径诱导皮肤血管舒张,包括NO、EDHF和感觉神经。局部应用的薄荷醇在30分钟内可在皮肤中检测到,并在60分钟内清除。皮肤血流量和感知指标与薄荷醇的出现/清除遵循相似的时间进程。